Cargando…
Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
Decoy receptor 3 (DcR3), a soluble glycosylated protein in the tumor necrosis factor receptor superfamily, plays a role in tumor and inflammatory diseases. Sepsis is a life-threatening organ dysfunction caused by the dysregulation of the response to infection. Currently, no specific drug that can al...
Autores principales: | Su, Jingqian, Tong, Zhiyong, Wu, Shun, Zhou, Fen, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454171/ https://www.ncbi.nlm.nih.gov/pubmed/37629097 http://dx.doi.org/10.3390/ijms241612916 |
Ejemplares similares
-
Research Progress of Macromolecules in the Prevention and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023) -
Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023) -
DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin
por: Gao, Liqin, et al.
Publicado: (2017) -
GATA4 and DcR1 methylation in glioblastomas
por: Vaitkienė, Paulina, et al.
Publicado: (2013) -
Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis()
por: Kim, Sunghee, et al.
Publicado: (2012)